Clinical Scholarship

Quality Improvement & Patient Safety Symposium Abstract Submissions

📅 Thursday, May 20th, 2021

QI Project Abstracts

Research Abstracts

QI Project Abstracts

Dr. Yoan Kagoma and Dr. Ja Ae (Shara) Kim; Kenneth Mascola, MRT(R)

A resident survey identified a desire for more detailed and personalized feedback during independent on-call periods. Prior studies have shown that automated information technology tools can help to facilitate meaningful feedback. Our primary aim was to minimize barriers to feedback and improve learning experiences for on-call radiology residents.

Graduated changes were made to the on-call workflow based on A3 problem solving method with root cause analysis of factors contributing to decreased resident satisfaction on quality of on-call feedback. Changes implemented included: workflow reorganization to match the daytime workflow, use of structured report templates, and implementation of automated report comparison function. Anonymous surveys were conducted pre- and post-implementation to evaluate resident satisfaction.

22 out of 25 and 15 out of 21 residents during different academic years responded to the pre-implementation and 7-weeks post-implementation surveys, respectively. Results were overall positive. 87% agreed that the changes were beneficial to overall call experience and learning. 55% felt they received adequate on-call feedback post-implementation compared to 23% pre-implementation. 73% agreed that the report comparison function was beneficial. Post-implementation respondents identified technical barriers as the main ongoing inconvenience to case follow-up.

Use of the A3 problem solving method to identify root causes and develop targeted interventions was useful to improve residents’ satisfaction on the quality of feedback received on their on-call reports. Facilitating automated and personalized feedback will be of increased importance in the era of Competency Based Medical Education.

N. Timilshina, A. Finelli, G. Tomlinson, A. Gagliardi, B. Sander, SMH. Alibhai

Although many low-risk prostate cancer (PC) patients worldwide currently receive active surveillance (AS), adherence to clinical guidelines on AS and variations in care at the population level remain poorly understood. We sought to develop system-level quality indicators (QIs) and performance measures for benchmarking the quality of care during AS.

We identified candidates for an expert panel among practising urologists and radiation oncologists across Canada. QI development involved two phases: (1) Proposed QIs were identified through a literature search and published clinical guidelines on AS and (2) indicator selection through a modified Delphi process during which each panelist independently rated each indicator based on clinical importance. QI items were chosen as appropriate measures for quality of AS care if they met prespecified criteria (disagreement index <1 and median importance of 7 or greater on a 9-point scale).

Among 42 invited expert panel members, the response rate was 45% (n=19). Expert panel members were well represented by type of physician (84% urologists, 16% radiation oncologists) and practice setting (67% academic, 33% non-academic). The expert panel endorsed 20 of 27 potential indicators as appropriate for measuring quality of AS care. The final set includes indicators covering structure of care (n=1), process of AS care (n=13) and outcomes (n=6). Two QIs were uncertain with median importance of 7 that has high disagreement index score (DI >1), and four QIs were uncertain with median importance 4-6 with DI >1.

We developed a set of QIs to measure AS care using published guidelines and clinical experts. Use of the indicators will be assessed for feasibility in healthcare databases. Reporting quality of care with these AS indicators may enhance adherence, reduce variation in care, and improve patients’ outcomes among low risk PC patients on AS.

Dr. Laura Olejnik, Dr. Sara Alavian, & Dr. Kyle Saikaley 

Emergency Medicine Residents, McMaster University

Opioid overdoses have reached new peaks in Canada since the beginning of the COVID pandemic, continuing to merit a public health response. The ED is a key interface where people who use opioids access care and often present with opioid-related harms. One harm reduction strategy that has shown efficacy in the community is take-home naloxone.1 This project aims to assess baseline rates of dispensing take-home naloxone.

This project will be organized into a data collection and an intervention phase. The first step will be to sample current naloxone kit distribution rate in opioid overdose presenting patients at the St Joseph’s Hospital. This data will denote the baseline use of naloxone distribution and can be used as comparison data points for local Emergency Hospitals. The data collected from the chart review will then be used to determine potential avenues of improvement as part of the Plan, Do, Study, Act (PDSA) cycle method to achieve the objectives previously stated. Such elements of implementation are predicted to be adding an order set, preparing take home naloxone kit and education information for both physician and patients.

Currently in data collection/no results, here we would like to highlight some of the parts of the project that did not go as planned. We’re QI researchers can encountered several delays including data extractions and Dovetail approval due to prioritizing of secondary projects such as needed COVID vaccine distribution, and manually tracking distribution of naloxone kits from pharmacy outside of Dovetail.

In the setting of St. Joseph's Healthcare Hamilton, no baseline data exists to identify the rates at which patients who present with an opioid-related encounter, such as overdose or otherwise, are being offered take-home naloxone kits and other harm reduction strategies. This project aims to utilize quality improvement (QI) methodology to assess the need and feasibility of a take-home naloxone protocol for our patient population who use opioids.

Justin M McGinnis, Rebecca Jones, Christopher Hillis, Heather Kokus, Heidi Thomas, Jason Thomas, Mohammad Alyafi, Laurence Bernard, Lua R. Eiriksson, Lorraine M. Elit, Hal Hirte, Waldo Jimenez, Clare J. Reade, Nidhi Kumar Tyagi, & Limor Helpman

Division of Gynecologic Oncology, McMaster University, Juravinski Hospital & Cancer Centre, Hamilton, Ontario, Canada 

International guidelines recommend pneumococcal pneumonia and influenza vaccination for all patients with solid organ malignancies prior to initiating chemotherapy. Baseline vaccination rates (March 2019) for pneumococcal pneumonia and influenza at our tertiary centre were 8% and 40%, respectively. The aim of this study was to increase the number of gynecologic chemotherapy patients receiving pneumococcal and influenza vaccinations to 80% by March 2020.

We performed an interrupted time series study using structured quality improvement methodology. Three interventions were introduced to address vaccination barriers: an in-house vaccination program, a staff education campaign, and a patient care bundle (pre-printed prescription, information brochure, vaccine record booklet). Process and outcome data were collected by patient survey and pharmacy audit and analyzed on statistical process control charts.

We identified 195 eligible patients. Pneumococcal and influenza vaccination rates rose significantly from 5% to a monthly mean of 61% and from 36% to a monthly mean of 67%, respectively. The 80% target was reached for both vaccines during one or more months of study. The in-house vaccination and staff education programs were major contributors to the improvement, whereas the information brochure and record booklet were minor contributors.

Three interventions to promote pneumococcal and influenza vaccination among chemotherapy patients resulted in significantly improved vaccination rates. Lessons learned about promoting vaccine uptake may be generalizable to different populations and vaccine types. In response to the global COVID-19 pandemic, initiatives to expand the program to all chemotherapy patients at our centre are underway.

Ravi Kumar MD, University of Ottawa & Humberto Vigil MD, MSc, FRCSC  

University of Ottawa, Division of Urology, Ottawa, Ontario

RightFaxâ„¢ is the digital faxing platform available at our institution. Although RightFax has been available since 2010, only 27 users have integrated it into their practice. The aim of our study was to increase the number of RightFax users within the Department of Surgery, by 50%, by March 31, 2021.

A time series analysis was performed to evaluate the impact of a virtual care onboarding initiative which included (1) streamlined onboarding instructions, (2) RightFax orientation/instructional videos, and (3) integrated RightFax-Epicâ„¢ workflows. The baseline number of users and digital faxes received prior to our interventions were obtained from IT services. Our primary outcome was the number of users onboarded. Secondary outcomes included the carbon footprint savings (calculated using the Hewlett-Packardâ„¢ carbon footprint calculator for paper), and user satisfaction.

From April 1st, 2020 to March 31, 2021, 118 new users were onboarded. A total of 137,713 pages of inbound faxes were saved, translating into a savings of 11832 kg of C02 emissions, 6000 kg of paper, and 13 thousand dollars in energy/paper costs. Nine administrative assistants were surveyed. 78% reported that RightFax was easy to use, 67% felt RightFax improved workflow and efficiency, and 89% were likely to recommend it to a colleague.

Increasing the number of digital faxing users through targeted onboarding initiatives successfully decreases an institution’s carbon footprint, costs, and improves workflow efficiency.

Chandra Farrer (1), Jennifer Price (1, 2),  Marie Pinard (1, 2),  Daryl Manankil (1), & Asif Ayenun (2)

  1. Women's College Hospital
  2. University of Toronto 

Improving patient access to personal health information is associated with improved: health knowledge; self-efficacy; satisfaction and communications. (HQO, 2019; Ramset et al. 2018; Rhudy et al. 2019). Baseline data showed a myHealthRecord (myHR) activation rate of 8.9%. The aim is to increase activation of myHR to 30% by Jun 2020.

Primary Outcome: Percentage of myHR activations. Process Measures: Patient usability/feedback, demographics, utilization of myHR features Balancing Measures: Staff Feedback, number of patients declined/ inactivated. A multipronged strategy of patient engagement, staff engagement, IT support, addition of features, and communications was implemented with iterative PDSA cycles to optimize myHR. Patient engagement consisted of two virtual patient focus groups and an electronic survey. Pre-pandemic, the organization planned to increase virtual care, using video visits conducted in myHR.

Patient engagement identified areas for improvement including: improved navigation, aligning clinic workflows to myHR features, interconnectivity, accessibility, and promotion of new features. Patients top 5 preferred features included: test results, health summary review, view past/upcoming appointments, plan of care review and appointment management. Gradual progressive increases in myHR activations occurred from inception with a dramatic increase to 66.7% during the pandemic with the launch of video visits to maintain ongoing access to health care.

The pandemic resulted in a culture shift regarding virtual care provision, resulting in dramatic increase in myHR activations. Substantial hospital resources were enabled to facilitate virtual care. The patient engagement will enable our team to further optimize myHR to ensure myHR meets the needs of patients to optimize patient experience.

Dr. Inna Berditchevskaia

McMaster Internal Medicine

In a rural hospital, inconsistent use of standardized admission order sets, when compounded with high staff turnover through locums and seasonal employment, leads to variability in care and potential medical error. This project’s aim was to increase the use of standardized order sets on admission to 70% over seven weeks.

Primary outcome measure: Proportion of admitted patients with a completed admission order set. Secondary outcome measures: Proportion of order sets correctly selected and completed. Process measures: Number and diversity of providers reporting confusion about order sets; diversity of providers completing order sets. Balancing measures: Staff satisfaction. A baseline audit was conducted with a review of one week’s admissions. Numerical trends were evaluated for intervention identification. Qualitative data from interviews was then used for intervention selection.

Baseline evaluation revealed a 56% completion rate on admission order sets, solely by emergency physicians, with a low uptake (16%) of appropriate diagnosis-specific order sets. Proposed interventions included: a staff meeting-based order set title review session, as physicians identified a lack of knowledge of available order sets; a transfer of care policy, as physicians identified confusion around responsibility for admission orders; and pre-printed order sets. Implementation was limited by the start of the COVID-19 Pandemic.

Shift in culture to evidence-based interventions requires engagement of diverse stakeholders. Evaluation of barriers also revealed deeper policy concerns, such as a lack of transfer of care policy. Finally, it is important to evaluate how interventions may continue in the setting of a paradigm shift, such as the COVID-19 Pandemic.

Shaily Brahmbhatt (1), Julie Ann Lawrence (3), Paulina Bleah (3), Amanda Mikalachki (3), Alan Gob (1, 2) ,  Kristin Clemens (1, 2) 

  1. Western University
  2. London Health Sciences Centre
  3. Kidney Care Centre 

Many patients with diabetes also live with advanced kidney disease requiring hemodialysis. It can be overwhelming for patients with multiple comorbidities to attend numerous appointments to receive care. This initiative aimed to develop an outreach diabetes care program lead by a Certified Diabetes Educator (CDE) at London Health Sciences Centre. 

We conducted a baseline needs assessment for diabetic patients receiving in-centre hemodialysis at the Kidney Care Centre (KCC) as of August 1, 2019. Once gaps were elicited, our team developed project aim statements. These included improvements to blood glucose self-monitoring, treatment adherence, episodes of hyperglycemia and hypoglycemia, and frequency of regular eye and foot care. We performed a root cause analysis to identify critical drivers of gaps and conceptualized diabetes supports for our outreach intervention.

Process, outcome and balancing measures were captured using run charts. Since December 2020, our CDE has provided outreach support every 1-2 months to 51 patients with diabetes, in-person and remotely, during the pandemic. Upon completing our program in the summer of 2021, we will formally analyze data using SPC software. Our outreach program appears to be improving the proportion with professional foot care, adequately self-monitoring sugars, and the mean number of blood sugars above 11. 

We have successfully implemented an outreach diabetes support program at the KCC. Our program appears to be improving glycemic control, regularity of foot and eye care, and disease knowledge in patients with diabetes undergoing hemodialysis.

Dr. Dana Trafford, Dr. Meera Joseph, Dr.Joy St. Onge, & Dr. Seychelle Yohanna

Falls occur annually in one-third of those over the age of 65. Falls predict hospitalization, functional decline and the need for long-term care. Falls occur frequently in inpatient dialysis patients. By March 2021, the aim was to decrease inpatient falls in hemodialysis patients on the Nephrology ward by 50%.

To better understand the circumstances and precipitating, we completed a retrospective chart review of all falls on the inpatient Nephrology ward between January to November 2019. This was followed by informal interviews with frontline staff for qualitative feedback. With this information, we completed a root cause analysis and explored change ideas that included patient, physician, nursing and environmental interventions.

We decided to focus on intervention that could be physician-led. Patients who fell were either on high falls-risk medications or delirious. Our aim was to change prescribing practices on the inpatient ward to reduce the incidence of delirium and falls. We attempted to obtain baseline data on inpatient prescribing practices from Dovetale. However, despite multiple requests and attempts, we were unable to obtain this crucial information. Therefore, we were not able to proceed further.

Barriers we faced prompted us to wonder if others pursuing QI projects in an academic hospital setting had similar experiences. There is a research gap in barriers and facilitators to pursuing QI projects in this setting. We are in the process of completing a qualitative study to explore this topic.

Selene Martínez*, Juan Segura, Stuart McCluskey, Marcin Wasowicz, Dallas Duncan, Ludwik Fedorko, Rose Ho, & Carlos Ibarra**

*Presenting author**Corresponding author

Residual neuromuscular blockade (NMB) after general anesthesia is a risk factor for postoperative respiratory complications, detectable only by quantitative NMB assessment, but often unrecognized by the anesthesiologist. The 2020 Guidelines to the Practice of Anesthesia of the Canadian Anesthesiologists’ Society, mandates the use of neuromuscular monitoring whenever NMB agents are administered. However, at our institution, NMB and reversal management predominantly relies on the anesthesiologist’s subjective assessment and clinical judgment. The OBISPO initiative intends to address this practice gap for improving our current standard of care.

Plan-Do-Study-Act (PDSA) improvement model. Outcome measure: incidence of residual NMB after general anesthesia (train-of-four ratio < 0.9 by electromyography). Process measure: NMB assessments rate in fast-track cardiac surgery patients; Fidelity: NMB assessments in > 70% patients per PDSA cycle. Balancing measures: trends of NMB and reversal agents dosing, PACU length-of-stay, time-to-extubation, adverse respiratory events, and staff satisfaction, per PDSA cycle.

QI interventions

From February 16 to May 12, 2021, 79 out of 213 patients underwent elective cardiac surgery and were admitted to PACU afterwards. In our first phase of assessment, 93% (27/29) of those patients had the train-of-four ratio (TOF) assessed and recorded in PACU prior to extubation. Residual NMB was present in 74% (20/27) fast-track cardiac surgery patients on arrival to PACU. Five (19%) were extubated with residual paralysis.

In our second Phase, 90% (28/31) had TOF assessed in PACU. Residual NMB decreased to 54% (15/28) and 7% (2/28) were extubated with residual paralysis. Finally, during the third phase we noticed that 89% (17/19) of patient had TOF recorded, 24% (4/17) had residual paralysis on arrival to PACU and only 6% (1/17) were extubated with residual paralysis.

The OBISPO initiative achieved a high fidelity on the initial PDSA cycle in terms of objective NMB assessments performed and recorded. Our focus will move to reducing the frequency of residual NMB in PACU after cardiac surgery, by encouraging the adoption of continuous intraoperative monitoring and a protocoled NMB management scheme.

Characteristics of Drug Poisonings Presenting to Emergency Department in Hamilton: A Retrospective Electronic Medical Record Review

Matthew Bell (1), Christine Wallace, Erich Hanel, Kaitlynn Rigg, & Anne Holbrook (2) 

  1. Pharmacy Resident, St Joseph’s Hospital Hamilton (SJHH)
  2. Director, Division of Clinical Pharmacology & Toxicology, Department of Medicine, McMaster University 

A literature review revealed no data on the epidemiology of drug poisonings presenting to hospitals in Ontario. This is despite an increase in the rate of accidental overdose deaths recently. We aimed to describe the demographics, drugs, medical management, and in-hospital outcomes poisonings seen in the Emergency Department at SJHH.

A descriptive, retrospective data extraction of Dovetale - EPIC® using ICD-10-CA coding for demographics, diagnoses and procedures, and direct extraction for medications including antidotes, referrals, and laboratory tests. Our primary outcome was the rate of drug poisonings presenting per 100,000 ED visits. Secondary outcomes included age, sex, postal code, and comorbidities of patients presenting, drugs involved, in-hospital treatments, services involved, and in-hospital outcomes for intentional versus unintentional poisonings.

Over 3 years, there were 3089 drug poisoning presentations to SJHH (741 admissions) involving 2304 patients, resulting in a rate of 898 poisonings per 100,000 ED Visits. The mean (SD) age of patients was 37.7 (16.6) years with 54.6 % female. Unintentional poisonings made up 1304 (42.2%) visits and were dominated by opioids (46.5% of poisonings involving an opioid) compared to a variety of causes of intentional poisonings - antidepressants (26.1%), benzodiazepines (24.8%), acetaminophen (22.0 %), and opioids (11.6%). Only 11.7% of patients received an addictions, social work, or mental health consult in ED and/or inpatient admission. With an overall in hospital mortality rate of 1.0 %.

The risk of recidivism in patients who presented with drug poisoning, predominance of opioids and the low rate of referral to addictions or mental health services are notable although the latter is confounded by data quality. This provides useful data on a high-risk group of patients but requires further analyses.

A Process Evaluation of a Virtual Client Experience Survey Pilot

Srushhti Trivedi, Anna Lee, & Fiqir Worku

University of Toronto Dalla Lana School of Public Health & Access Alliance Multicultural Health and Community Services

In 2020, Access Alliance identified a virtual mode of collecting client data using a combination of telephone and email media during the COVID-19 pandemic titled the Virtual Client Experience Survey (V-CES). The aim of this project was to evaluate the V-CES with respect to process measures.

The process evaluation consisted of i) a literature review, ii) an environmental scan of relevant V-CES documents, and iii) an analysis of the V-CES using quality, effectiveness, efficiency, scalability, and reach indicators. The process evaluation team developed indicators and measurements from the literature. Survey results from the CES 2019 and V-CES 2020 were compared and interviews with relevant Access Alliance staff members were included in data collection.

Reach indicators showed a diverse range of clientele with challenges obtaining survey data from patients under 18 and over 65. The efficiency analysis demonstrated a higher completion rate among email survey invitations. Phone surveys, were particularly useful in reaching typically hard-to-reach older patients. The heavy reliance on students in the administration led to the recommendation of a contingency protocol in the event that placement students may not be available.

This process evaluation has supported an understanding of access to the V-CES across Access Alliance’s clientele. The impact of the COVID-19 pandemic has inevitably hampered the effectiveness, efficiency, and quality of V-CES process activities. Nonetheless, the V-CES pilot is a great example of how client feedback can be collected in a resource-limited environment which is scalable to other community health centres.

Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study

Anne Holbrook MD PharmD, MSc, Harsukh Benipal MSc, J. Michael Paterson MSc, Diana Martins MSc, Simon Greaves MSc, Munil Lee BHSc, & Tara Gomes PhD MHSc

Oral anticoagulants are commonly used high-risk medications, but little is known about their safety in transition from hospital to home. Our objective was to measure the rates of hemorrhage and thromboembolic events among older adults discharged on oral anticoagulants, during the first month post- hospital discharge compared to later.

We conducted a retrospective population-based cohort study among Ontario residents aged 66 years or older who started, continued or resumed oral anticoagulant therapy at hospital discharge between September 2010 and March 2015. We calculated the rates of hemorrhage and thromboembolic events requiring hospital admission or an emergency department visit over a 1-year follow-up period, stratified by the first 30 days after discharge and the remainder of the year. We used multivariable regression models, adjusting for covariates, to estimate the effect of sex, prevalent versus incident use, and switching anticoagulants on events.

A total of 123139 patients (68408 women [55.6%]; mean age 78.2 yr) were included. About one-quarter (32 563 [26.4%]) had a Charlson Comorbidity Index score of 2 or higher. The rates of hemorrhage and thromboembolic events per 100 person-years were highest during the first 30 days after hospital discharge (25.8, 95% CI 24.8–26.8 and 19.3, 95% CI 18.4–20.2, respectively), falling to 15.7 (95% CI 15.3–16.1) and 6.9 (95% CI 6.6–7.1), respectively, during the subsequent 11 months. Multivariable analysis showed that patients whose anticoagulant was switched in hospital and men had more hemorrhages and thromboembolic events in follow-up.

The first few weeks following hospital discharge represent a very high-risk period for adverse events related to oral anticoagulant treatment among older adults. The results support an intervention trial addressing anticoagulation management in the early post-discharge period.

Research Abstracts

Dr. Brian J Chan & Lily Xu (MD Candidate)

COVID-19 safety precautions makes informed decision-making a more challenging process for patients. This is an opportunity for healthcare providers to integrate patient decision aids into practice, an intervention to enhance patient experience. This study explores whether video-based patient decision aids (VBPDA) can facilitate patient decision making in the cataract surgery consent process.

Before the clinical encounter, patients watched the VBPDA, which outlined the process of cataract surgery and the decisions to be made (ie. biometry, intraocular lens, and focus). During the clinical encounter, patients had a consultation with an ophthalmologist and engaged in shared decision making. At the end of the encounter, all patients completed a questionnaire assessing the effects of COVID-19 safety precautions on their appointment. Patients proceeding with surgery also completed the Decisional Conflict Scale (DCS).

For patients proceeding with cataract surgery (n=111), the median DCS score was 9.4 (0-54.7, min-max) on a scale of 0 to 100 (low to high decisional conflict). Of these, 76 participants (68.5%; 95% CI: 0.60-77.0%) scored < 25, 30 participants (27.0%; 19.0-36.0%) scored between 25-37.5, and 5 participants (4.5%; 1.5-10.0%) scored > 37.5, representing low, medium, and high decisional conflict, respectively.

COVID-19 health precautions have made it more difficult to communicate the decisions that patients need to make before their cataract surgeries, presenting challenges to the consent process. Our study found that VBPDAs to be an effective tool to enhance the patient decision making process for cataract surgery.

Potentially to include video based methods of patient education in other predictable procedures as well, as it makes the encounter both more efficient and effective. Patients are more satisfied and the efficiency decreases their risk of exposure in COVID. Beyond COVID, efficiency will be necessary to allow patients to receive care in a timely manner.

Dileas Macgowan (MD Candidate) & Dr. Samuel Silver

Research indicates 34% of Canadian family physicians caring for patients receiving hemodialysis do not receive any reporting from nephrologists. Locally, reports are sent to family physicians monthly, requiring significant nephrologist time and effort. This audit aimed to examine the use and value of these reports to primary care providers.

We conducted a survey study of family physicians who care for patients receiving hemodialysis in the Queen’s University nephrology program. The survey evaluated the percentage of family physicians who reviewed the report monthly and found its content useful for patient care. Based on expected current performance of 50% for both metrics and desired performance of >80%, a target sample of 12 physicians was required to demonstrate a quality of care gap.

Thirteen family physicians completed the survey. 84% (11/13) indicated they always review the report and 15% (2/13) indicated they review the report over 50% of the time. Additionally, 77% (10/13) of respondents view the report as very (23%, 3/13) or somewhat (54%, 7/13) useful. All respondents included medication lists as the most important content of these dictations. Further, 85% (11/13) listed role delineation (e.g., primary responsibility for depression management, cancer screening, etc) as valuable content.

Contrary to our expectation based on prior informal feedback, reports were reviewed by primary care physicians regularly (i.e., every 4-6 weeks). This supports the nephrologist effort being dedicated to current practice. Instead, improvement is needed in dictation content, particularly listing medications and clearly delineating primary responsibilities for different care tasks.

Marla Campbell MBA, PMP,  Dr. C. Rabbat & Dr. D. Perri

eFax is the process when an electronic medical record generates a paperless prescription and electronically transmits to an Ontario outpatient pharmacy’s fax machine. eFax is to promote efficient workflows to support healthcare workers, reduce patient safety risks (e.g. photocopying) and keep patient information secure (e.g. non-authorized interception, anti-forgery microfont). eFax is a patient centred functionality improving the patient experience, enabling virtual care and social distancing during the pandemic.

Pilot scope included 8 Ambulatory Nephrology areas between June 16th – July 9th 2020. Users were Prescribers with the support of Clerical Staff to manage eFax Rx Notice Pool which showed the status of sent eFaxes. Only prescribers have the authority to dual authenticate (eSign) and send eFaxes. The eFax workflow consists of 4 process steps in contrast to the 9-10 faxing process steps.

Between June 16th – July 9th 2020, 631 eFax prescriptions were sent with a 98.1% successful transmissions rate. The eFax process saved 35 seconds to print & sign prescription and 87 seconds to travel & fax prescription. It is projected to save the department 40.14 hours / month. Prescription can be prepared before a patient arrives to pharmacy saving patient time and providing convivence. User feedback included the process being user friendly, fast and efficient and they liked the ability to work remotely.

For patients, eFax means less stress and waiting at the pharmacy especially if their health is not great and less exposure to infection for immunocompromised patients. For prescribers, efficiencies mean more time to spend on patient value-add tasks including the opportunity to see more patients within a day. eFax secured workflows including the addition of a destination pharmacy, a microfont line and dual authentication. In contrast, printed prescriptions for faxing can be intercepted by non-authorized users at the printer or fax machine and paper copies need to be managed appropriately.

Hanu Chaudhari (1), Michelle Schneeweiss (1), Reid Rebinsky (1), Enrico Rullo (1), & Mohamed Eltorki (2)

  1. Medical Student. Medicine, McMaster University Faculty of Health Sciences, Hamilton, ON, Canada. 
  2. Principal Investigator. Pediatrics, McMaster University, Hamilton, ON, Canada.

Appendicitis accounts for 7-10% of acute abdominal pain cases presenting to the emergency department. Nursing directives in the ED have previously been shown to decrease ED length of stay, time to imaging, and improve pain control. An advanced nursing directive could expedite the diagnostic workup for children with suspected appendicitis.

Inclusion Criteria: Children aged 3-17 years presenting with ≤4 days of abdominal pain, right lower quadrant (RLQ) pain with walking or jumping and tenderness or guarding on palpation. Exclusion Criteria: Chronic GI/GU illness or neurodevelopment disorder. Statistical Analysis: Categorical variables were summarized using frequencies, proportions, and rates. Continuous variables were summarized using means, medians, and standard deviations. For differences in proportions, we conducted a χ2 test and for continuous variables we used student t-test

Nurse-initiated investigations for suspected pediatric appendicitis patients had a mean reduction in time from ED presentation to all diagnostic and therapeutic ED flow parameters when compared to MD-initiated standard of care. There was no significant difference in proportion of patients who had a surgical appendectomy between those who were investigated using the nursing directive (32.8%) and those who were MD-initiated (30.0%) (Pearson’s chi square 0.185, p-value 0.758).

A nursing directive selects intermediate to high risk patients for appendicitis & empowers nurses to begin the diagnostic work-up. Nurse-initiated investigations for suspected pediatric appendicitis had quicker diagnostic and therapeutic outcomes and did not result into an increase in resource utilization.

Alisa Lagrotteria (1), Andrew Lagrotteria (2),  & Keith Tsoi (3)

  1. McMaster University, Department of General Internal Medicine, Hamilton
  2. Temerty Faculty of Medicine, University of Toronto, Toronto
  3. McMaster University, Department of Gastroenterology, Hamilton

More than 45 million people globally are affected by chronic liver disease (CLD) - with incidence expected to rise. CLD results in a complex immunocompromised state, leaving patients defenceless in the face of infection and at a 4-fold risk of mortality. Immunization remains our best line of defence. The National Advisory Committee on Immunization Practices recommends special immunization considerations for patients with CLD against vaccine-preventable disease, including vaccination against hepatitis A virus (HAV), hepatitis B virus (HBV), pneumococcal pneumonia, and influenza. The degree of successful implementation of vaccine programs in response to guidelines for CLD patients is not well understood.

The aim of this quality assessment study examine rates and timing of vaccine administration in patients with CLD, in an effort to mitigate potential disparities in coverage and the potential harm of vaccination delay.  Problem description 3.5 Aim 1

Patients with CLD who received care at a large, primary care academic center in Ontario between January 1, 2010 and June 30, 2020 were identified using diagnostic codes. Demographics, etiology, and vaccination data pertaining to influenza, pneumococcus, HAV, and HBV were collected utilizing the electronic medical record and Canadian Primary Care Sentinel Surveillance Network database. 

Of 23, 021 patients registered, a total of 150 patients were identified to have CLD.  The average age of the cohort was 55 and 25.3% (n = 38) were older than 65 at time of diagnosis. 58.7% (n = 88) were male. Overall, 32% (n = 48) of patients with CLD received at least 1 vaccination following their diagnosis. The rate of having at least 1 influenza vaccine after diagnosis was 28% (n = 42), of which 66.7% (n = 28) were vaccinated within 1 year after diagnosis. The rate of having at least 1 lifetime pneumococcal vaccine was 26% (n = 39), of which 12.8% (n = 5) were within 1 year after diagnosis.  Analysis revealed that 6% (n = 9) of patients initiated vaccination against HAV, of which 44.4% (n = 4) initiated the series within 1 year after diagnosis.  55.6% (n = 5) completed the full schedule. 10% (n = 15) of the total cohort initiated vaccination against HBV, with 4.7% (n = 7) having initiated the series within 1 year after diagnosis. Only 2 patients completed the full schedule for HBV vaccine. Another 10 patients (6.7%) initiated dual-HepA/B vaccination, of which 3 patients (30%) did so within 1 year following diagnosis. Only 3 patients (30%) completed the full series. 

Dr. Sarah J. Mah MD, FRCSC (1) & Dr. Julie My Van Nguyen MDCM, MSc, FRCSC (2)

  1.  Gynecologic Oncology Fellow McMaster University
  2. Assistant Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology

Gender and racial minority representation in academic leadership in Canadian Departments of Obstetrics and Gynecology (OBGYN) and Divisions of Gynecologic Oncology (GO) has not been previously described. Our objective was to examine gender and ethnic diversity in departmental leadership roles.

Institutional websites were queried in 01/2021 to compile a list of faculty members of academic departments. Subjective gender was assigned based on photographs and pronouns. Visible minorities were identified from photographs. Descriptive statistics were used to summarize faculty characteristics. Logistic regression analysis was performed to examine prognostic factors for leadership roles.

355(33.7%) male and 698(66.3%) female academic OBGYNs were identified across 16 Canadian institutions; no physicians of non-binary gender were identified. Visible minorities comprised 18.3% of academic OBGYNs. Men were more likely than women to reach full professorship (p-value<0.00001) and to be appointed to leadership positions including Chair of OBGYN (p-value=0.0004) or subspecialty Division Head (p-value<0.00001). Visible minority physicians were less likely to have attained full professorship (p-value=0.002), but there was no statistical difference in ethnic representation in leadership roles. Within GO, 97 academic physicians were identified: 68(70.1%) were female, 17(17.5%) were visible minorities. Seven departments (44%) did not have visible minority representation. Factors associated with leadership positions on univariate analysis (Department Chairs, Division Heads, Fellowship, Residency and Undergraduate Program Directors) were academic title (odds ratio [OR]=2.91,95%CI=1.19-7.11,p-value=0.019 for Professor/Associate Professor vs Assistant Professor/Lecturer) and year of fellowship completion (OR=0.95,95%CI=0.91-0.99,p-value=0.014). Gender or being from a visible minority were not significant factors. On multivariable analysis, only year of completion of fellowship was predictive of leadership roles in GO. 

This is the first study to describe gender and ethnic representation in the Canadian OBGYN landscape. Despite underrepresentation of women in leadership and full-professor positions, and visible minority underrepresentation in full-professorship in OBGYN, no such difference was observed amongst academic Gynecologic Oncologists.

Anne Holbrook (1), Mei Wang, Marilyn Swinton, Sue Troyan, Joanne Ho, Deborah Siegal (2)

  1. Director, Division of Clinical Pharmacology and Toxicology and Professor, Department of Medicine, McMaster University, Hamilton, ON, Canada. 
  2. Associate Professor, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Oral anticoagulants (OACs) are commonly prescribed and highly effective medications, but a leading cause of serious medication-related adverse events. High-quality OAC management, has become more complex now that there are several direct-acting OACs (DOACs). This study aimed to identify barriers and facilitators for optimal OAC management using qualitative research methods.

Using a qualitative descriptive study design, we conducted five focus groups, three with patients and caregivers and two with health care providers, in two health regions in Southwestern Ontario. An expert facilitator led the discussions using a semi-structured interview guide. Each session was digitally recorded, transcribed verbatim and anonymized. Transcripts were analyzed in duplicate using conventional content analysis, consistent with a qualitative descriptive approach.

42 informants, including 19 patients, 7 caregivers, and 16 providers, participated in the discussions. Data analysis organized codes describing barriers and facilitators into 4 main themes - medication-related, patient-related, provider-related, and system-related. Barriers highlighted were problems with medication access due to cost, patient difficulties with adherence, knowledge and adjusting their lifestyles to OAC therapy, and provider expertise and time for adequate communications. Facilitators addressed these barriers

Many barriers to optimal OAC management exist even in the era of DOACs, many of which are amenable to facilitators of improved care coordination, patient education, and adherence monitoring. Since there is not yet high quality evidence that interventions to address these barriers actually improve clinical outcomes in a cost-effective manner, further research is required before policies can be created.

A Quality Improvement Project to Reduce Off-label Telemetry Utilization in Nephrology Inpatients

Meherzad Kutky MD MSc & Seychelle Yohanna MD MSc

Division of Nephrology, Department of Medicine, St. Joseph’s Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada 

Telemetry monitoring is often overused in non-ICU settings. The Choosing Wisely campaign has identified telemetry utilization as a target for reduction and has advocated that non-ICU telemetry should only be used when indicated and systems should be in place for the discontinuation of telemetry. We utilized an interrupted time series design to evaluate telemetry utilization in all patients admitted to nephrology in the 16-month preintervention period and 12-month post intervention period. The charts for all patients admitted to nephrology (ward patients only) who were ordered telemetry were reviewed. We collected the indication for telemetry, the duration. We compared the ordering indication with AHA guidelines both pre and post intervention.

Telemetry indications were modified to align more closely with the AHA guidelines. Our primary outcome measure was the percentage of class III (not-indicated) telemetry ordered. This dropped from a median of 56% to 23% and sustained over the course of a 12 month period. We also created a pilot medical directive to stop telemetry after 48hr for the most common indications, which lowered the amount of prolonged telemetry by 35% without any documented adverse events.

Our pilot project showed a sustained decrease in the percentage of class III telemetry, and our medical directive pilot was effective without any documented adverse events. Next steps will be apply our medical directive and collect data once it is fully implemented.

Evaluating deprescribing opportunities in Intensive Care

Alisa Lagrotteria, MD (1 ), Mia Geromella, MSc (2), and Cindy Hameilec, MD, FRCP (3)

  1. Department of Medicine, McMaster University, Hamilton, Ontario
  2. Department of Applied Health Sciences, Brock University, St. Catherine’s, Ontario
  3. Department of Critical Care, McMaster University, Hamilton, Ontario

The prevalence of potentially inappropriate medications (PIMs) in older adults is a pervasive public health concern. A presentation to the Intensive Care Unit (ICU) affords an opportunity to review and reduce prescribing harm.  The objective of this study was to evaluate the deprescribing practices of PIMs in an ICU setting. 

We evaluated deprescribing practices of potentially inappropriate medications (PIMs) following admission to ICU in a tertiary hospital in Hamilton, Ontario. A retrospective chart review was conducted on patients who were 60 years or older, hospitalized between June 1, 2013 and June 1, 2015. Medications listed in the 2015 Beer’s Criteria and opioids without a cancer diagnosis were marked as PIMs. Discharge records were used to identify PIMs that were deprescribed.

72 patients of mean age 72.3, with an average of 2.6 co-morbidities were included in the study. Of patients admitted and discharged from ICU, 88.8% and 81.9% were on at least one or more PIM, respectively. In total, 190 of 621 (30.6%) of all medications at ICU admission were identified as PIMs, and 50.5% (n=96) of these were deprescribed. The mean number of PIMs prescribed at ICU admission was 2.64, compared to 1.92 at ICU discharge (p=0.01). The most frequently deprescribed were opioids (26%), antipsychotics (26%), anti-hypertensives (17%), and NSAIDs (17%).

Inappropriate prescribing is found frequently in older adults at admission to ICU. In evaluating deprescribing practices in an ICU at a tertiary care center, we found that a significant number of PIMs had been deprescribed per patient at time of ICU discharge. Overall, more than 50% of PIMs were discontinued at ICU discharge. This suggests that admission to ICU may present an opportune time to improve medication use amongst older adults.  

Postoperative management of pediatric patients undergoing minimally invasive repair of pectus excavatum: where are we now?

McMaster University, Hamilton, Ontario, Canada 

Minimally invasive repair of pectus excavatum (MIRPE) often leads to a painful and challenging recovery period. This study aims to describe the postoperative management of pediatric patients undergoing MIRPE and compare postoperative outcomes between patients using different primary modes of analgesia.

Retrospective chart review of pediatric patients who underwent MIRPE from July 2003 to September 2019 at a single pediatric tertiary care centre. Data on pain management and course of hospital stay were ascertained.  Descriptive statistics, Mann-Whitney U and Pearson Chi-Square tests were used to analyze data. A p-value <0.05 was considered significant. Of 115 patients identified, 58(50.4%) managed pain postoperatively using thoracic epidural and 57(49.6%) intravenous patient-controlled analgesia (IVPCA). Transition from the predominant use of epidural to IVPCA for MIRPE occurred between 2012 and 2013. Significantly higher pain scores were reported by the IVPCA group at 6, 12 and 48 hours postoperative. IVPCA group had lower postoperative opioid consumption (p<0.001) and shorter hospital stay (4 days [4, 5]) compared to the epidural group (5.5 [5, 6]; p<0.001).

This study provides a framework for understanding trends in postoperative outcomes following MIRPE. Patients using IVPCA reported higher pain scores, however this mode of analgesia was associated with shorter hospital stay. Prospective studies designed to address moderator variables are required to confirm findings and develop standardized recovery protocols.

Planning Committee

Dr. Amna Ahmed, Internal Medicine

Clare O'Connor, RN Quality Specialist, HHS

Dr. Shawn Mondoux, Emergency Medicine

Dr. Dominik Mertz, Infectious Disease

Dr. Inge Schabort, Family Medicine

Dr. Seychelle Yohanna, Nephrology